From Computers to Community Development: How Ismael Ssemakula is Lighting Up Kalungu West

From Computers, iron sheets to supporting community development, Ismael Ssemakula lights up Kalungu West A Man with a Vision While each of us pursues our own individual dreams, one man among the many thinks about lighting up, developing Kalungu’s multi sectoral departments. From thirst for service, Lenore and to making Kalungu West a thriving model…

Read More

Innovative, Articulate, and Easy to Follow: Former BitMEX CEO Arthur Hayes Backs Memecoin Pepe with $250,000 Bet

The Rise of Memecoins: Arthur Hayes’ Impact on the Crypto Market Arthur Hayes and the Memecoin Sector Arthur Hayes, co-founder and former CEO of the cryptocurrency trading platform BitMEX, has recently made headlines with significant investments in the memecoin sector, particularly through his notable purchase of Pepe (PEPE). Hayes’ optimism towards memecoins, expressed in a…

Read More

“Uh-oh! PowerSchool Data Breach Under Investigation by Levi and Korsinsky – What You Need to Know”

PowerSchool Data Breach: A Lesson in Online Security What Happened? Recently, PowerSchool made the unfortunate announcement that they experienced a data breach. This breach resulted in the exposure of sensitive personal information belonging to students, parents, and teachers. The news of this breach has sparked widespread concern about the security of our personal data in…

Read More

“Meet Ted Carefoot: The Newest Addition to Our Product Dream Team at Scope Technologies!”

Welcome to the Future with Quantum-Proof Security Exciting News from Scope Technologies Corp! Vancouver, BC, Jan. 31, 2025 /PRNewswire/ — Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) (“Scope” or the “Company”) is thrilled to announce the appointment of Ted Carefoot as Vice President of Product. Carefoot, a tech wizard with a history of…

Read More

Mark Your Calendars: Quoin Pharmaceuticals to Share Third Quarter 2022 Financial Results and Exciting Corporate Updates on November 10th!

Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th… ASHBURN, Va., Nov. 01, 2022 (GLOBE NEWSWIRE) Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, has announced that its third quarter 2022 financial results will be reported on Thursday, November…

Read More